Tau phosphorylation at other locations, such as threonine 231 (pTau231) and serine 235, can differentiate Alzheimer's disease from other related disorders, such as frontotemporal lobar degeneration, vascular dementia, and dementia with Lewy bodies. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.